Rep. Andy Biggs

No Mandates Act This bill prohibits federal agencies and certain entities that receive federal funding from requiring COVID-19 vaccinations. Specifically, federal agencies may not issue rules, regulations, or guidance that require an individual to receive a COVID-19 vaccination. The bill also prohibits requiring a COVID-19 vaccination to access federal property and services or congressional grounds and services. Additionally, an entity that received federal COVID-19 relief funds or receives other federal funds after this bill's enactment may not require a COVID-19 vaccination as a condition of providing any service to an individual.

This bill nullifies Order 2021-148 of the Mayor of the District of Columbia (December 22, 2021) and any successor or substantially similar order of the Mayor of the District of Columbia that imposes a COVID-19 vaccine requirement for entry to certain establishments and facilities in the District.

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.

Protecting Our Democracy by Preventing Foreign Citizens from Voting Act This bill prohibits federal funds from being made available to state or local governments that allow noncitizens to vote in federal, state, or local elections.

Stop Federal Vaccine Mandates for Employees Act This bill prohibits the Occupational Safety and Health Administration from issuing any emergency temporary standard that requires an employee to receive a drug, vaccine, or other biological product.

Answer COVID FOIAs Now Act This bill addresses pending Freedom of Information Act (FOIA) requests related to COVID-19. Specifically, the bill requires each federal agency, within 100 calendar days, to complete all pending FOIA requests related to a drug or medical device to prevent, diagnose, mitigate, or treat COVID-19; gain-of-function or potential pandemic pathogen research; or a policy, rule, or standard requiring COVID-19 vaccination of individuals. For each calendar day on which any applicable FOIA request remains pending, the Department of the Treasury must transfer $1 million from the appropriations account of the office of the head of the agency to the Countermeasures Injury Compensation Program of the Health Resources and Services Administration. A person submitting such a request shall be deemed to have demonstrated a compelling need for expedited processing.

This bill posthumously provides for the award of a Congressional Gold Medal in commemoration of the 13 service members who died on August 26, 2021, while stationed at Hamid Karzai International Airport in Afghanistan.

Border Agents Stay Employed Act or the BASE Act This bill prohibits using federal funds to require any U.S. Customs and Border Protection officer or employee to receive a COVID-19 vaccine.

No Tax Dollars for the United Nation's Immigration Invasion Act This bill prohibits the federal government from making contributions to the United Nations (U.N.) International Organization for Migration, the U.N. High Commissioner for Refugees, or the U.N. Relief and Works Agency for Palestine Refugees in the Near East.

Maddy summaryHR 6105 terminates the federal public health emergency declaration for COVID-19, ending the status effective December 25, 2021. This bill directly affects federal programs and authorities operating under the emergency declaration, such as expanded telehealth services and pandemic-related funding. The key provision is a specific termination date for the emergency status declared under Section 319 of the Public Health Service Act. It does not create new policies but ends the legal authority for emergency measures. The bill is procedural, focusing solely on ending the declared emergency.